iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.41 by 2.44 percent. This is a 16.67 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $19.51 million which beat the analyst consensus estimate of $19.33 million by 0.93 percent. This is a 10.87 percent increase over sales of $17.60 million the same period last year.